secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2024-12-31T23:59:59+00:00
Accession:  0001193125-24-287172
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 1.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma amends exchange agreement for internal EPA holdings restructuring
--------------------------------------------------------------------------------

- Amended Exchange Agreement transfers Holdings C Share from RPI EPA Holdings to RPI EPA Vehicle.
- Articles of association of Royalty Pharma Holdings Limited amended and restated.
- Restructuring involves equity performance awards (EPA) entity substitution.
- No changes to publicly traded Royalty Pharma plc's operations or financials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524287172/0001193125-24-287172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524287172/d900232d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-287172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer